BETA

4 Amendments of Roberta METSOLA related to 2017/2150(DEC)

Amendment 3 #
Draft opinion
Paragraph 3
3. Regrets the Court’s finding that one of the Centre’s employees, acting as an Authorising Officer, was appointed to evaluation committees, took award decisions and signed contracts for two framework contracts despite the fact that this possibility was not explicitly authorised by his/ther delegation of powers fromgranted by the Authorising Officer; welcomes the commitment of the Centre to adjust the content of its delegation of powers accordingly and to put in place the adequateffective control measures to prevent such occurrences;
2018/01/19
Committee: LIBE
Amendment 4 #
Draft opinion
Paragraph 5
5. Highlights the release of over 44 scientific and institutional publications; welcomes especially the publication of the flagships “2016 European Drug Report (EDR) package” and of the joint “EMCDDA–Europol 2016 EU Drug Markets Report”; notes as well that a total of 27 scientific articles or book chapters authored or co-authored by the Centre’s staff were also published during the year, enhancing the Centre’s scientific reputation;deleted
2018/01/19
Committee: LIBE
Amendment 8 #
Draft opinion
Paragraph 6
6. Stresses that the Centre did not respect the ceiling of a framework contract, which was signed in 2012 with a maximum amount for signing specific contracts of EUR 250 000, as by the end of 2015 the total payments made under this contract amounted to EUR 382 181; calls on the Centre to improveensure the effectiveness of the procedure for monitoring framework contracts;
2018/01/19
Committee: LIBE
Amendment 11 #
Draft opinion
Paragraph 7
7. EncouragWelcomes the commitment of the Centre to provide improved access to its data to interested third parties; expects that such a commitment has to result in actions taken in this regard.
2018/01/19
Committee: LIBE